Global Multi Cancer Early Detection Market Research Report 2023

Publication ID:

PB502236571

Publication Date:

February 2, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Multi-cancer early detection (MCED) tests are听tests that measure biological signals in body fluids that may be shed by cancer cells. These signals are also known as biomarkers or tumor markers. MCED tests are being developed to screen for cancers from more than one organ site at the same time.
Highlights
The global Multi Cancer Early Detection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Multi Cancer Early Detection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Multi Cancer Early Detection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Multi Cancer Early Detection in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Multi Cancer Early Detection include Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx, Guardant Health, Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine, Inc. and Singlera Genomics Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Multi Cancer Early Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi Cancer Early Detection.
The Multi Cancer Early Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Multi Cancer Early Detection market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi Cancer Early Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Grail, LLC (Illumina, Inc.)
Exact Sciences Corporation.
Foundation Medicine, Inc.
AnchorDx
Guardant Health, Inc.
Burning Rock Biotech Limited
GENECAST
Laboratory for Advanced Medicine, Inc.
Singlera Genomics Inc.
Segment by Type
Liquid Biopsy
Gene Panel, LDT & Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi Cancer Early Detection companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi Cancer Early Detection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Liquid Biopsy
1.2.3 Gene Panel, LDT & Others
1.3 Market by Application
1.3.1 Global Multi Cancer Early Detection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi Cancer Early Detection Market Perspective (2018-2029)
2.2 Multi Cancer Early Detection Growth Trends by Region
2.2.1 Global Multi Cancer Early Detection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multi Cancer Early Detection Historic Market Size by Region (2018-2023)
2.2.3 Multi Cancer Early Detection Forecasted Market Size by Region (2024-2029)
2.3 Multi Cancer Early Detection Market Dynamics
2.3.1 Multi Cancer Early Detection Industry Trends
2.3.2 Multi Cancer Early Detection Market Drivers
2.3.3 Multi Cancer Early Detection Market Challenges
2.3.4 Multi Cancer Early Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multi Cancer Early Detection Players by Revenue
3.1.1 Global Top Multi Cancer Early Detection Players by Revenue (2018-2023)
3.1.2 Global Multi Cancer Early Detection Revenue Market Share by Players (2018-2023)
3.2 Global Multi Cancer Early Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multi Cancer Early Detection Revenue
3.4 Global Multi Cancer Early Detection Market Concentration Ratio
3.4.1 Global Multi Cancer Early Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi Cancer Early Detection Revenue in 2022
3.5 Multi Cancer Early Detection Key Players Head office and Area Served
3.6 Key Players Multi Cancer Early Detection Product Solution and Service
3.7 Date of Enter into Multi Cancer Early Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi Cancer Early Detection Breakdown Data by Type
4.1 Global Multi Cancer Early Detection Historic Market Size by Type (2018-2023)
4.2 Global Multi Cancer Early Detection Forecasted Market Size by Type (2024-2029)
5 Multi Cancer Early Detection Breakdown Data by Application
5.1 Global Multi Cancer Early Detection Historic Market Size by Application (2018-2023)
5.2 Global Multi Cancer Early Detection Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Multi Cancer Early Detection Market Size (2018-2029)
6.2 North America Multi Cancer Early Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multi Cancer Early Detection Market Size by Country (2018-2023)
6.4 North America Multi Cancer Early Detection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multi Cancer Early Detection Market Size (2018-2029)
7.2 Europe Multi Cancer Early Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multi Cancer Early Detection Market Size by Country (2018-2023)
7.4 Europe Multi Cancer Early Detection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multi Cancer Early Detection Market Size (2018-2029)
8.2 Asia-Pacific Multi Cancer Early Detection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multi Cancer Early Detection Market Size by Region (2018-2023)
8.4 Asia-Pacific Multi Cancer Early Detection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multi Cancer Early Detection Market Size (2018-2029)
9.2 Latin America Multi Cancer Early Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multi Cancer Early Detection Market Size by Country (2018-2023)
9.4 Latin America Multi Cancer Early Detection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multi Cancer Early Detection Market Size (2018-2029)
10.2 Middle East & Africa Multi Cancer Early Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multi Cancer Early Detection Market Size by Country (2018-2023)
10.4 Middle East & Africa Multi Cancer Early Detection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grail, LLC (Illumina, Inc.)
11.1.1 Grail, LLC (Illumina, Inc.) Company Detail
11.1.2 Grail, LLC (Illumina, Inc.) Business Overview
11.1.3 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Introduction
11.1.4 Grail, LLC (Illumina, Inc.) Revenue in Multi Cancer Early Detection Business (2018-2023)
11.1.5 Grail, LLC (Illumina, Inc.) Recent Development
11.2 Exact Sciences Corporation.
11.2.1 Exact Sciences Corporation. Company Detail
11.2.2 Exact Sciences Corporation. Business Overview
11.2.3 Exact Sciences Corporation. Multi Cancer Early Detection Introduction
11.2.4 Exact Sciences Corporation. Revenue in Multi Cancer Early Detection Business (2018-2023)
11.2.5 Exact Sciences Corporation. Recent Development
11.3 Foundation Medicine, Inc.
11.3.1 Foundation Medicine, Inc. Company Detail
11.3.2 Foundation Medicine, Inc. Business Overview
11.3.3 Foundation Medicine, Inc. Multi Cancer Early Detection Introduction
11.3.4 Foundation Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2018-2023)
11.3.5 Foundation Medicine, Inc. Recent Development
11.4 AnchorDx
11.4.1 AnchorDx Company Detail
11.4.2 AnchorDx Business Overview
11.4.3 AnchorDx Multi Cancer Early Detection Introduction
11.4.4 AnchorDx Revenue in Multi Cancer Early Detection Business (2018-2023)
11.4.5 AnchorDx Recent Development
11.5 Guardant Health, Inc.
11.5.1 Guardant Health, Inc. Company Detail
11.5.2 Guardant Health, Inc. Business Overview
11.5.3 Guardant Health, Inc. Multi Cancer Early Detection Introduction
11.5.4 Guardant Health, Inc. Revenue in Multi Cancer Early Detection Business (2018-2023)
11.5.5 Guardant Health, Inc. Recent Development
11.6 Burning Rock Biotech Limited
11.6.1 Burning Rock Biotech Limited Company Detail
11.6.2 Burning Rock Biotech Limited Business Overview
11.6.3 Burning Rock Biotech Limited Multi Cancer Early Detection Introduction
11.6.4 Burning Rock Biotech Limited Revenue in Multi Cancer Early Detection Business (2018-2023)
11.6.5 Burning Rock Biotech Limited Recent Development
11.7 GENECAST
11.7.1 GENECAST Company Detail
11.7.2 GENECAST Business Overview
11.7.3 GENECAST Multi Cancer Early Detection Introduction
11.7.4 GENECAST Revenue in Multi Cancer Early Detection Business (2018-2023)
11.7.5 GENECAST Recent Development
11.8 Laboratory for Advanced Medicine, Inc.
11.8.1 Laboratory for Advanced Medicine, Inc. Company Detail
11.8.2 Laboratory for Advanced Medicine, Inc. Business Overview
11.8.3 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Introduction
11.8.4 Laboratory for Advanced Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2018-2023)
11.8.5 Laboratory for Advanced Medicine, Inc. Recent Development
11.9 Singlera Genomics Inc.
11.9.1 Singlera Genomics Inc. Company Detail
11.9.2 Singlera Genomics Inc. Business Overview
11.9.3 Singlera Genomics Inc. Multi Cancer Early Detection Introduction
11.9.4 Singlera Genomics Inc. Revenue in Multi Cancer Early Detection Business (2018-2023)
11.9.5 Singlera Genomics Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Grail, LLC (Illumina, Inc.)
Exact Sciences Corporation.
Foundation Medicine, Inc.
AnchorDx
Guardant Health, Inc.
Burning Rock Biotech Limited
GENECAST
Laboratory for Advanced Medicine, Inc.
Singlera Genomics Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂